Found 35 matching trials
Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period PHASE4 This study will test the well-known medicine turoctocog alfa for any side e...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A N/A This study is conducted in Europe, and North and South America. The aim of ...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A PHASE1 Sobi.BIVV001-003 is an open-label, 2-period, fixed sequence study for intra...
Show More Location
Sobi Investigational Site
Learn More & Join Trial
Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015 PHASE3 This trial is conducted in Asia, Europe, Japan, Oceania, North America and ...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A PHASE3 This study will look at how a known study medicine N8-GP works in previousl...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Post-Marketing Surveillance (Use-results Surveillance) With Esperoct® N/A The purpose of this study is to assess the safety and effectiveness of Espe...
Show More Location
Kurume University Hospital, Pediatrics
Learn More & Join Trial
Safety and Efficacy in a ReAl-Life Study in Patients With Haemophilia Treated wIth NovoEight® for Surgery N/A the aim of the SERAPHINE study is to gather data stemming from the French r...
Show More Learn More & Join Trial
Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A PHASE1 This trial is conducted globally. The aim of this clinical trial is to inve...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A PHASE1 This trial is conducted globally. The aim of this trial is evaluating the p...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Study Investigating Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A Patients N/A The trial is conducted in North America. The aim of the trial is to assess ...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial